Chromosome 11p15 deletion is frequent in human tumors, suggesting the presence of at least one tumor suppressor gene within this region. While mutation analyses of local genes revealed only rare mutations, we have previously described a mechanism, gain of imprinting, that leads to loss of expression of genes located on the maternal 11p15 chromosome in human hepatocarcinomas. Loss of expression was often associated with loss of maternal-speci®c methylation at the KvDMR1 locus. Here, we show that loss of the maternal KvDMR1 methylation is common, ranging from 30 to 50%, to a variety of adult neoplasms, including liver, breast, cervical and gastric carcinomas. We found that other 11p15.5 loci were concomitantly hypomethylated, indicating that loss of KvDMR1 methylation occurred in the context of a common mechanism aecting the methylation of a large 11p15 subchromosomal domain. These epigenetic abnormalities were not detected in any normal somatic tissue. Therefore, it seems possible that, contrary to the repression of promoter activity caused by hypermethylation, loss of gene expression at 11p15.5 may result from the activation, by hypomethylation, of one or more negative regulatory elements.
Introduction
DNA methylation is an essential mechanism for the regulation of gene expression in mammalian cells (Eden and Cedar, 1994) . Methylation occurs at cytosine residues within CpG dinucleotides and many genes are enriched with these dinucleotides in their promoters. These regions are known as CpG islands and are generally non-methylated, a condition that allows genes to be transcriptionally competent. Methylation of CpG islands within gene promoters leads to transcriptional silencing through recruitment of methyl-CpG binding proteins (MeCPs) and histone deacetylases (HDACs) (Nan et al., 1998) . Hence, identi®cation of the methylation patterns of CpG islands in mammalian cells is important for understanding normal and pathologic gene expression.
Several reports have shown that abnormal hypermethylation of CpG islands may contribute signi®-cantly to the pathogenesis of human cancer (Baylin et al., 1998; Cooper and Youssou®an, 1988; Robertson and Wole, 2000) . Hypermethylation of promoters associated with tumor suppressor genes or genes involved in DNA stability is detected with increased frequency in a variety of human neoplasms. This mechanism provides an alternative route to gene mutation, leading to silencing and functional inactivation of tumor suppressor genes.
The presence of at least one tumor suppressor gene at chromosome 11p15 has been suggested by the detection of deletions in various human neoplasms (Baa et al., 1996; Bepler and Garcia-Blanco, 1994; Henry et al., 1989; Kiechle-Schwartz et al., 1993; O'Briant and Bepler, 1997) . In addition, the linkage of 11p15 to the cancer-predisposing Beckwith ± Wiedemann syndrome (BWS) further supported the concept that a cancer-predisposing gene is located within this region (Koufos et al., 1989) . However, mutation analyses of 11p15 genes revealed only rare mutations: in the CDKN1C gene in BWS (Hatada et al., 1996) and SLC22A1L (also known as BWR1A, IMPT1, ORCTL2 and TSSC5) in few human neoplasms (Lee et al., 1998; Schwienbacher et al., 1998) . These ®ndings suggest that epigenetic changes, rather than gene mutations, may cause inactivation of 11p15 tumor suppressor genes. Indeed, epigenetic abnormalities at 11p15 have been frequently detected. Chromosome 11p15.5 is the location of one of the two regions of the human genome with the highest density of imprinted genes, and CpG methylation plays a key role in controlling imprinted gene expression. Two known parentalspeci®c dierentially methylated imprinting centers (ICs), H19-IC1 and KvDMR1 (IC2), were found to be abnormally methylated in cancer and BWS: hypermethylation of maternal H19-IC1 allele was discovered in BWS and Wilms' tumors (Catchpoole et al., 1997; Steenman et al., 1994) and loss of maternal-speci®c methylation at KvDMR1 was found in BWS and liver carcinomas (Engel et al., 2000; Schwienbacher et al., 2000b; Smilinich et al., 1999) . H19-IC1 and KvDMR1-IC2 are CpG islands dierentially methylated on the two parental chromosomes. H19-IC1, located just 5' to the H19 gene, is methylated on the paternal chromosome, and KvDMR1, located within intron 10 of the gene KvLQT1, is methylated on the maternal chromosome (Smilinich et al., 1999) . These dierentially methylated regions regulate gene expression over long distances (Hark et al., 2000; Horike et al., 2000; Webber et al., 1998) and their abnormal methylation was found to alter normal expression of various 11p15 genes (Brown et al., 1996; Cleary et al., 2001; Engel et al., 2000; Moulton et al., 1994; Schwienbacher et al., 2000b) .
To verify whether 11p15.5 epigenetic abnormalities could be speci®cally associated with the neoplastic phenotype, we searched for epigenetic abnormalities at these and other 11p15 loci in dierent human neoplasms. The most common abnormality was loss of CpG methylation, which was found to occur at the same time in various 11p15.5 loci, including KvDMR1. In addition, we found dierences in the epigenotypes of adult and pediatric tumors (Wilms').
Results

Analysis of KvDMR1 methylation in adult and childhood tumors
Tumor samples included 42 hepatocarcinomas, 58 breast, 19 gastric, 37 colorectal, 17 cervical and 24 vulvar carcinomas, and 12 Wilms' tumors. We analysed the methylation status of the dierentially methylated HpaII sites (CCGG) within the KvDMR1 locus by Southern blot and by a HpaII-duplex-PCR. Southern blot hybridization with probe AA155639 (Mitsuya et al., 1999) of genomic DNA digested with the restriction enzymes BamHI and HpaII can distinguish the 6.0 kb fully methylated maternal allele from the 2.6 kb non-methylated paternal allele ( Figure  1a) . Initially, we assessed the KvDMR1 methylation status of 11 normal somatic tissues derived from skeletal muscle, kidney, liver, stomach, lung, breast, ovary, bladder, uterus, placenta and peripheral blood. As expected, all the normal samples revealed the normal imprinted pattern of DNA methylation ( Figure  1g ). On the contrary, studies performed on tumor samples revealed that full or partial loss of KvDMR1 methylated allele was present in 10 of 22 (45.5%) hepatocarcinomas, in four of eight (50%) gastric carcinomas, in 13 of 34 (38%) breast carcinomas, in three of nine (33%) cervical carcinomas, two of three vulva carcinomas, none of nine colorectal carcinomas and in seven of 12 Wilms' tumors. Selected results are shown in Figure 1 . Additional samples, for which we had only a limited amount of material, were analysed by HpaII-duplex-PCR (Figure 2) No association was found with histopathological features of tumors.
Simultaneous loss of methylation at other 11p15 loci
To evaluate whether loss of methylation at the KvDMR1 locus was unique within the imprinted region at chromosome 11p15.5, we analysed CpG methylation at other 11p15.5 loci in the same tumor samples. We analysed methylation status of two candidate matrix attachment regions (MARs), discovered by scanning the genomic nucleotide sequence of the region using the online sequence analysis tool MAR-Finder (http:// www.ncgr.org/MarFinder/) (Figure 3) , and the promoter of the SLC22A1L gene, which overlaps with the putative BWR1B gene. Methylation analysis of these loci (probes MAR-R, MAR-L1, BWR1A-BWR1B) revealed that, with few exceptions at single loci, there was either a simultaneous loss or maintenance of methylation at the various loci in each tumor DNA ( Figure 3 and Table 2 ). All human cancers analysed, including liver, breast, cervical and gastric carcinomas revealed hypomethylation at MAR-L1, KvDMR1 and SLC22A1L promoter, while hypomethylation of MAR-R was found only in hepatocarcinomas.
Analysis of H19-IC1 methylation in adult and childhood tumors
Some of the same samples described in the previous sections were analysed for CpG methylation at the H19 locus. Genomic DNAs were analysed by Southern blot using H19 probe 1 (Frevel et al., 1999) (Figure 4a ). Hybridization of 10 dierent normal tissues (skeletal muscle, kidney, stomach, lung, breast, ovary, bladder, uterus, placenta and peripheral blood) con®rmed the dierential maternal/paternal imprinted methylation. From the analysis of adult tumor samples derived from 14 liver, 11 gastric, 15 breast, nine colorectal, 11 cervix Oncogene and three vulva carcinomas, none displayed alterations of the methylation pattern. In all cases, the 360 bp fragment relative to the unmethylated maternal allele was visible (Figure 4c ). In contrast, among 12 WTs, only two displayed a normal imprinted methylation and the remaining 10 showed only a hypermethylated con®guration ( Figure 4b ). As indicated by LOH studies (next section), the absence of the non-methylated allele could be attributed to abnormal maternal allele methylation in three of them (WT7, WT10, WT12) and to physical loss by deletion (or parental uniparental disomy) of maternal allele in the others.
In summary, all adult tumors presenting aberrant demethylation at the KvDMR1 maternal allele, did not display methylation abnormalities at the H19 locus and the three Wilms' tumors presenting abnormal epigenetic hypermethylation of H19 maternal allele did not display simultaneous loss of KvDMR1 methylation. These data indicate that epigenetic mechanisms causing aberrant methylation at H19 and KvDMR1 occur independently.
Loss of heterozygosity at 11p15
To verify whether the detected abnormalities of the maternal-speci®c methylation at the H19 and KvDMR1 imprinting centers were caused by a deletion aecting the maternal chromosome or by abnormal methylation, we performed LOH studies using the following 11p15 polymorphic loci: the microsatellites D11S1388, Figure 1 Southern blot analysis of KvDMR1 methylation in human tumors. Genomic DNAs from tumor samples were doubledigested with BamHI and HapII, a methylation-sensitive restriction enzyme. Hybridization was performed with probe AA155639 (Mitsuya et al., 1999) (a) The ®gure shows representative selected results from hybridizations of liver (b), cervical (d), breast (e), colorectal carcinomas (f), Wilms' tumors (c) and normal tissues (g). Control for lack of inhibition of restriction digestion was obtained by re-hybridization of blots shown in panels e and f with a STIM-1 probe (Sabbioni et al., 1999) (h,i) . The KvDMR1 maternal allele is detectable as a 6.0 kb fragment, whereas the paternal one is detectable as a 2.6 kb fragment. Several of the tumor samples, and none of the normal controls displayed loss of the maternal methylated allele. Additional normal tissues from liver are shown in Figure 3 . In each blot, control lanes included normal genomic DNAs digested with either BamHI (Bm), BamHI and MspI (a methylation-insensitive HpaII isoschizomer) (Bm-Msp) or BamHI and HpaII (Bm-Hp). Pat, paternal; Mat, maternal; *complete or partial loss of methylation; Cen, centromere; Tel, telomere D11S1318 and D11S922 and intragenic polymorphisms present in the CDKN1C, IGF2 and SLC22A1L genes. LOH studies were performed in liver, breast and gastric carcinomas and Wilms' tumors.
For hepatocarcinomas, the studies have been previously reported (Schwienbacher et al., 2000b) : none of the samples displayed LOH at any of the 11p15 loci. In breast and gastric carcinomas, LOH at 11p15 was analysed among samples with KvDMR1 demethylation. Of 19 breast carcinomas, only four (21%) displayed also LOH for at least one 11p15 locus, and in gastric carcinomas, only one of four (25%) samples had also LOH. These results lead to the conclusion that loss of maternal KvDMR1 methylation in human adult tumors was largely the result of an epigenetic mechanism.
In Wilms' tumors, LOH was detected in seven of 12 informative cases. Remarkably, loss of maternal KvDMR1 methylation was observed only among the cases with LOH, indicating that it was the consequence of the physical loss of maternally-derived chromosomal DNA. Similarly, all the LOH cases lost also the unmethylated H19 maternal allele, but three (WT7, WT10 and WT12) of the ®ve (WT7, 9, 10, 12 and 14) samples with retention of heterozygosity showed an epigenetically hypermethylated H19 maternal allele. Retention of DNA heterozygosity excluded uniparental paternal disomy as a mechanism converting maternal H19 epigenotype into paternal. In WT7, which is heterozygous for an intragenic IGF2 polymorphism, we could demonstrate, as expected, biallelic expression of the IGF2 gene.
These results indicate that LOH and loss of KvDMR1 methylation in adult tumors occur independently, while they are strictly associated in Wilms' tumors. On the other hand, in Wilms' tumors, H19 hypermethylation can be detected independently from LOH, while we have not detected this event in adult neoplasms.
Discussion
This work demonstrates that complete or partial loss of methylation at various 11p15.5 loci is common in Figure 2 HpaII-Duplex PCR on human tumor samples. The 502 bp band reveals the presence of the maternal methylation KvDMR1 allele, while its absence re¯ects loss of methylation. Ampli®cation with a second set of primers (11A-T7-C/11A-T3-E), which amplify a 342 bp fragment lacking internal HpaII sites, served as control for DNA ampli®cation. (a) A reconstruction experiment to assess the power of PCR ampli®cation for revealing a methylated KvDMR1 allele within a tumor DNA harboring exclusively non-methylated KvDMR1 loci. Various combinations of methylated/non-methylated KvDMR1 alleles were obtained by a serial 1 : 2 dilution of 50 ng HpaII-digested normal DNA (NL) into 50 ng HpaII-digested hepatocarcinoma DNA (HCC). The following dilutions were obtained and analysed: 0, 100% normal; 1, 50% normal and 50% HCC; 2, 25% normal and 75% HCC; 3, 12% normal and 88% HCC; 4, 6% normal and 94% HCC. This experiment reveals that, under the employed experimental conditions, the product corresponding to a normal KvDMR1 methylated allele begins to be detectable by ethidium bromide staining when present as 6 ± 12% of the total. (b,c) Representative results from analyses performed on gastric, vulvar and cervical neoplasms. The QUANTITY-ONE program (Bio-Rad) was used for the densitometric quanti®cation of visualized bands. Loss of KvDMR1 methylation was scored when the ratio between intensities of KvDMR1 and control bands was below the ratio of the condition detecting 25% normal DNA, as in the reconstruction experiment of panel a. *Complete or partial loss of methylation; B, blank, PCR reaction with no template DNA; M, molecular weight marker 123 base pair ladder Oncogene human adult neoplasms. This ®nding supports the concept of the existence of a subchromosomal domain in this region, whose epigenotype is coordinately regulated. Indeed, the existence of a subchromosomal domain, whose boundaries have yet to be de®ned, would explain why hypomethylation in human tumors spans several hundreds, or more, kilobases. Among the hypomethylated loci, loss of maternal-speci®c KvDMR1 methylation was detected. Since this epigenetic abnormality has been associated with abnormal expression of various 11p15.5 genes, it may also represents a trait involved in the pathogenesis of human cancer. This possibility does not exclude that hypomethylation of other, yet to be de®ned, loci may have a similar pathogenetic function, by altering expression of the same or other local genes. The absence of full KvDMR1 epigenetic abnormalities or LOH in colon carcinoma may re¯ect the non-involvement of 11p15 genes in the pathogenesis of this tumor.
We have also shown that abnormal methylation at the two known imprinting centers at chromosome 11p15.5, H19 and KvDMR1, occurs independently. Loss of KvDMR1 maternal methylation is largely prevalent in adult neoplasms, and present in Wilms' tumors only in association with the physical loss of maternal chromosomal material; instead, hypermethylation of H19, frequently detectable in Wilms' tumors, is not present in adult neoplasms. Another observation that warrants some considerations is the presence of intermediate-sized bands in the hybridization patterns detected at the KvDMR1 locus (detectable in particular in colorectal carcinomas and Wilms' tumors shown in Figure 1 , although weak intermediate-sized bands can also be seen in liver, cervical and breast carcinoma samples). Theoretically, these bands could be generated either by partial methylation of paternal alleles or partial loss of methylation of maternal alleles. In colorectal tumors, both alternatives are possible, but Figure 3 Simultaneous hypomethylation at various 11p15 loci. A simpli®ed gene map of the imprinted region at chromosome 11p15.5 is shown. The map displays genes (gray boxes), location of H19 and KvDMR1 imprinting centers IC1 and IC2 and of the MAR-R and MAR-L1 loci (black ovals). Above the map is the graph of the scores calculated by the program MAR-Finder that reveals the presence of two potential MAR elements. Drawing is not on scale. cen, centromere; tel, telomere. Below the map, Southern blot analyses of various 11p15.5 loci, MAR-R, MAR-L1, BWR1A-BWR1B and KvDMR1, in human hepatocarcinomas. Hypomethylation at various 11p15.5 loci is present in HCC samples, but not in normal matched liver. Remarkably, maintenance or loss of methylation appeared to be a trait characteristic of various loci at 11p15.5 in each tumor sample. HCC, hepatocellular carcinoma; Li, matched non-neoplastic liver. Probes used for hybridization are described in Materials and methods. For each probe, location and BamHI and HpaII restriction map are shown in the lower panels. Sizes of BamHI fragments are indicated. Kb, kilobases since loss of maternal methylation was seen in all adult neoplasms, we suspect that in colorectal and other adult tumors, these intermediate-sized bands could just represent incomplete loss of methylation of KvDMR1 maternal alleles in a fraction of tumor cells. Conversely, in Wilms' tumors, in which deletion of maternal chromosome 11p15 is frequent, the intermediate-sized bands cannot derive from maternal chromosomes. Hence, it seems logical to conclude that, in Wilms' tumors, KvDMR1 intermediate-sized bands are likely to derive from partial methylation of paternal non-methylated alleles. The above observations suggest that 11p15 epigenotypes of adult and pediatric tumors are dierent not only in their pattern but also in their genesis, and may imply that dierent pathogenetic mechanisms link chromosome 11p15.5 to adult and pediatric solid tumors. Furthermore, in adult neoplasms, abnormal methylation at 11p15.5 is observed more frequently than LOH, while in Wilms' tumors LOH is more frequent than abnormal methylation. The reason for this dierence is unclear, but both mechanisms could lead to the inactivation of 11p15 maternal cancer genes: in one case, by changing an epigenetic maternal-speci®c mark into paternal; in the second, by physically removing all the maternallyexpressed genes.
In spite of possible functional overlaps, aberrant methylation at H19-IC1 or KvDMR1 is likely to target dierent 11p15.5 genes. H19-IC1 methylation is known to control parental-speci®c expression of H19 and IGF2. In adult tumors, no abnormality has been detected at the H19 locus, whereas in Wilms' tumors H19 maternal allele is aected either by physical deletion or by somatic hypermethylation. The importance of the H19-IC1 locus in Wilms' tumors is supported by the observation that abnormal methylation imprint at this locus is frequent in the Beckwith-Wiedemann embryonic overgrowth syndrome (Weksberg et al., 1993) , in which WT is the most frequently associated neoplasm. In addition, tumorigenicity of the kidney rhabdoid tumor cell line G401 is suppressed by transfection of the H19 gene (Hao et al., 1993) . Thus, genes controlled by H19-IC1 are likely to play a primary role in the pathogenesis of WTs and possibly other pediatric solid tumors but only a minor role in adult tumors. On the other hand, abnormal methylation of the maternal KvDMR1-IC2 locus is frequent in adult neoplasms and occurs in WTs only as a consequence of LOH. This result suggests that genes controlled by KvDMR1-IC2, and/or other hypomethylated loci, may be important in the pathogenesis of adult neoplasms, without excluding their involvement in WTs. Among the genes regulated by KvDMR1, two reports have directly indicated that CDKN1C expression is negatively in¯uenced by KvDMR1 (Horike et al., 2000; Schwienbacher et al., 2000b) . SLC22A1L may, in some cases, be also in¯uenced (Schwienbacher et al., 2000b) . Loss of KvDMR1 methylation could also alter allelic expression of IGF2 (Horike et al., 2000; Schwienbacher et al., 2000b) . However, since hypomethylation spans a large region and several loci at chromosome 11p15, it may have an eect on various 11p15 regulatory elements and genes, which in combination could promote tumorigenesis. At present, it is not possible to identify a single critical gene in the region and various local genes remain potential candidates (Lee et al., 1998; Schwienbacher et al., 1998 Schwienbacher et al., , 2000a .
In contrast to several recent reports, which indicate promoter hypermethylation as a pathogenetic mechanism in human cancer, our results reveal a frequent loss of methylation. Although an overall decrease in DNA methylation is frequent in tumorigenesis (Ehrlich, 2000) , the present ®nding is apparently dicult to explain, because region 11p15 has been associated with human cancer by LOH studies, suggesting the presence of tumor suppressor genes. To date, only promoter hypermethylation has been shown to inactivate tumor suppressor genes, while hypomethylation has been eventually suggested to activate oncogenes. How can these apparently con¯icting observations be reconciled? Our data suggest that hypomethylation could lead to gene repression possibly through the reactivation of negative regulatory elements. Indeed, hypermethylation does not necessarily cause gene silencing. For example, methylation of the H19 imprinting center at chromosome 11p15 causes H19 silencing but, at the same time, activates the IGF2 silent maternal allele (Bell and Felsenfeld, 2000 ; Table 2 Simultaneous hypomethylation at various 11p15 loci in human neoplasms Taniguchi et al., 1995) . Hence, for the IGF2 gene, silencing is associated with IC1 lack of methylation and activation is associated with IC1 hypermethylation. Thus, methylation processes may be viewed as mechanisms that control either the positive or the negative function of any DNA regulatory element. Because of the dierential methylation, KvDMR1 may function dierently on the two parental chromosomes. It has been hypothesized that it may function as a boundary element separating CDKN1C from telomeric enhancers . According to this hypothesis, methylation would allow CDKN1C expression by blocking the KvDMR1 insulator element, with a mechanism similar to the H19 insulator (Bell and Felsenfeld, 2000) , but with opposite parental speci®city. Methylated, KvDMR1, present on the maternal chromosome and inactivated by methylation, would lead the CDKN1C gene active. If this mechanism is correct, loss of KvDMR1 maternalspeci®c methylation would convert the maternal into paternal imprint and reveal the putative insulator activity, resulting in CDKN1C repression. Demonstration of a KvDMR1 insulator activity and identi®cation of a telomeric enhancer are still awaited to be proven.
In conclusion, our results indicate that tumor-speci®c loss of KvDMR1 methylation occurs frequently in adult tumors, which may induce the reactivation of a KvDMR1 negative regulatory function. This circumstance causes deregulation, most often repression, of a subset of genes active on the maternally derived chromosome, a condition that may promote tumorigenesis.
Materials and methods
Tumor DNA samples
All DNAs derived from normal tissues and histopathologically diagnosed liver, breast, gastric, colon, cervical, vulval, Figure 4 Southern blot analysis of H19 methylation status in human tumors. Genomic DNAs from tumor samples were doubledigested with BamHI and HpaII. Hybridization was performed with H19 probe 1 (Frevel et al., 1999) . (a) Location of the H19 probe 1, used to detect the dierentially methylated IC1 region at the 5' of the H19 gene. The ®gure shows results from the analysis of Wilms' tumors (b), colorectal and gastric carcinomas (c). The maternal allele is detectable as a 360 bp fragment. The apparent absence of the paternal methylation H19 allele in all carcinomas is possibly due to a variable extension of methylation 3' to the H19 gene on the paternal chromosome, producing a ladder of fragments, which are dicult to visualize individually. Indeed, faint bands can be seen in the size range where the paternal allele is expected. Control lanes included normal genomic DNAs digested with either BamHI (Bm), BamHI and MspI (Bm-Msp). Mat, maternal; *Complete or partial loss of maternal allele ovarian carcinomas and Wilms' tumors were prepared by standard SDS/proteinase K digestion and phenol/chloroform puri®cation (Maniatis et al., 1982) . Histopathologically, all tumor samples were non-selected malignant invasive carcinomas. Various stages and grades were represented.
Southern blot analysis
Southern blot transfer and hybridization was performed using standard conditions (Maniatis et al., 1982) . For methylation analyses, genomic DNAs were digested overnight at 378C with BamHI and the methylation-sensitive HpaII restriction enzymes. As a control, DNA was digested with BamHI and MspI, a methylation-insensitive isoschizomer of HpaII. DNA was separated on a 1% agarose gel and transferred to a Hybond N + membrane (Amersham). The membranes were subsequently hybridized with a-32 P dCTPlabeled probe, at 428C for 16 h in 50% formamide, 66SSPE, 1% sodium dodecyl sulphate, 56Denhardt's solution and 100 mg/ml denatured salmon sperm DNA solution. Washes were in 26SSC, 0.1% sodium dodecyl sulphate at 658C. The program QUANTITY-ONE (Bio-Rad) was used for the densitometric quanti®cation of bands.
